Bristol-Myers Squibb
BMY
$46.40
Share price
-1.99%
Change (1 day)
15.57%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Net assets
Net assets on the balance sheet as of March 2025 : $17.44 Billion USD
According to Bristol-Myers Squibb's latest financial reports the company has $17.44 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Bristol-Myers Squibb - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$16.38 B | -44.42% |
| 2023-12-31 | $$29.48 B | -5.25% |
| 2022-12-31 | $$31.11 B | -13.58% |
| 2021-12-31 | $$36.00 B | -4.95% |
| 2020-12-31 | $$37.88 B | -26.72% |
| 2019-12-31 | $$51.69 B | 265.95% |
| 2018-12-31 | $$14.12 B | 19.25% |
| 2017-12-31 | $$11.84 B | -27.53% |
| 2016-12-31 | $$16.34 B | 13.33% |
| 2015-12-31 | $$14.42 B | -3.73% |
| 2014-12-31 | $$14.98 B | -1.66% |
| 2013-12-31 | $$15.23 B | 11.72% |
| 2012-12-31 | $$13.63 B | -14.05% |
| 2011-12-31 | $$15.86 B | 1.46% |
| 2010-12-31 | $$15.63 B | 5.77% |
| 2009-12-31 | $$14.78 B | 21.11% |
| 2008-12-31 | $$12.20 B | 15.58% |
| 2007-12-31 | $$10.56 B | 5.72% |
| 2006-12-31 | $$9.99 B | -10.86% |
| 2005-12-31 | $$11.20 B | 9.86% |
| 2004-12-31 | $$10.20 B | 4.25% |
| 2003-12-31 | $$9.78 B | 11.76% |
| 2002-12-31 | $$8.75 B | -3.52% |
| 2001-12-31 | $$9.07 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $90.63 B | 419.47% | 🇺🇸 USA |
 Merck MRK | $48.40 B | 177.40% | 🇺🇸 USA |
 Eli Lilly LLY | $15.84 B | -9.18% | 🇺🇸 USA |
 Novartis NVS | $38.45 B | 120.38% | 🇨🇭 Switzerland |
 Sanofi SNY | $80.51 B | 361.44% | 🇫🇷 France |
 AstraZeneca AZN | $41.13 B | 135.73% | 🇬🇧 UK |
 Johnson & Johnson JNJ | $78.10 B | 347.67% | 🇺🇸 USA |
 AbbVie ABBV | $1.46 B | -91.62% | 🇺🇸 USA |
 Amgen AMGN | $6.20 B | -64.43% | 🇺🇸 USA |
 Biogen BIIB | $16.97 B | -2.69% | 🇺🇸 USA |